Myocardiodystrophy

Myocardial dystrophy is a non-inflammatory lesion of the heart muscle as a result of disturbances in its metabolism under the influence of extracardiac factors.

Etiology. Myocardial dystrophy can develop with acute and chronic exogenous intoxication, including alcohol, endocrine and metabolic disorders (thyrotoxicosis, myxedema, Cushing's syndrome, obesity, diabetes mellitus, vitamin deficiencies, starvation), anemia, pathological menopause, physical overexertion (“soldier's heart”) , infections, exposure to physical factors (radiation, weightlessness, overheating), systemic diseases (diffuse connective tissue diseases, neuromuscular dystrophy, etc.). Myocardial dystrophies also include the deposition in the myocardium of pathological metabolic products or normal metabolites: amyloid, iron, glycogen, etc.

Pathogenesis. With myocardial dystrophy, a change in biochemical processes in the myocardium occurs, which leads to disruption of the microstructures and contractile function of muscle fibers. These changes are reversible at the initial stage.

Clinical manifestations are often masked by symptoms of the underlying disease. Increased fatigue, slight shortness of breath during physical activity, and weakening of the first heart sound are noted. As the disease progresses, heart failure and arrhythmias develop. ECG changes are nonspecific.

Diagnostics includes differential diagnosis with coronary heart disease, myocarditis, cardiomyopathies.

Treatment is aimed at eliminating the underlying disease, limiting physical activity, correcting metabolic disorders, and prescribing drugs that improve myocardial metabolism (riboxin, potassium orotate, cocarboxylase, beta-blockers). With adequate therapy, the prognosis is favorable.

Myocardial Dystrophy: Understanding and Treating Heart Disease

Myocardial dystrophy, also known as myocardiodystrophia, is a heart disease that affects the structure and function of the myocardium, the muscle of the heart. This condition is characterized by degeneration or dystrophy of the myocardium, which can lead to cardiac dysfunction and heart failure.

Myocardial dystrophy has a variety of causes, including genetic factors, congenital heart abnormalities, inflammation, autoimmune diseases, toxic exposure, and long-term stress on the body. The causes of myocardial dystrophy can be varied, and in some cases the exact cause remains unknown.

One of the main manifestations of myocardial dystrophy is a weakening of the contractility of the heart muscle and a decrease in its ability to effectively pump blood throughout the body. This can lead to symptoms such as fatigue, shortness of breath, lack of energy, swelling and palpitations. Patients may also experience chest tenderness, arrhythmia, and decreased physical endurance.

Diagnosis of myocardial dystrophy involves performing a physical examination as well as using various educational methods such as electrocardiogram (ECG), echocardiography, magnetic resonance imaging (MRI) and cardiac catheterization. These methods help determine the extent of myocardial damage and identify possible complications.

Treatment of myocardial dystrophy is aimed at eliminating or mitigating symptoms, as well as slowing the progression of the disease. In some cases, medications such as beta blockers and ACE inhibitors may be prescribed to control the arrhythmia and reduce the strain on the heart. More severe cases may require cardiac surgery, including heart transplantation.

However, along with traditional treatment methods, in recent years, research has been actively carried out in the field of regenerative medicine and cell therapy. These methods are aimed at stimulating the regeneration of damaged cardiac tissue and restoring its function.

It is important to note that myocardial dystrophy is a serious disease that requires an integrated approach to treatment and patient care. Regular consultations with your cardiologist, following lifestyle recommendations (including physical activity, a healthy diet, and avoiding stress), and taking prescribed medications can help manage symptoms and slow the progression of the disease.

In conclusion, myocardial dystrophy is a heart disease characterized by myocardial degeneration and dysfunction. The causes of myocardial dystrophy can be varied, and diagnosis is based on examination and clinical methods. Treatment is aimed at eliminating symptoms and slowing the progression of the disease. A comprehensive approach to treatment and patient care plays an important role in managing myocardial dystrophy and improving quality of life.

Myocardial dystrophy is a group of heart diseases that are characterized by disruption of its function and structure. These diseases can be caused by a variety of factors, including genetic factors, infections, autoimmune processes, metabolic disorders, and exposure to various chemicals and radiation.

Myocardial dystrophies can be found in people of any age, but most often they occur in people over 50 years of age. They can be either mild or severe, and can lead to various complications such as heart failure, arrhythmias, myocardial infarction and others.

Various methods are used to diagnose myocardial dystrophies, including echocardiography, magnetic resonance imaging, and myocardial biopsy. Treatment depends on the type of myocardial dystrophy and may include lifestyle changes, medication, and surgery.

In general, myocardial dystrophies are a serious disease that can lead to serious complications. Therefore, it is important to conduct regular examinations and monitor your health to prevent the development of this disease.